Beryl Drugs Promoter Acquires 7500 Shares On-Market

Beryl Drugs Ltd discloses insider trading Form C under SEBI PIT Regulations 2015 for promoter share acquisition.
Promoter & Director Sudhir Sethi acquired 7,500 equity shares on BSE on 23 March 2026 for ₹1,15,620.
Post-acquisition, Sudhir Sethi's holding increased from 4,78,983 (9.44%) to 4,86,483 shares (9.58%).